Related Experiment Videos
Histologically negative specimens after induction therapy: frequency and impact on survival
1Department of Otolaryngology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Avda. San Antoni M(a) Claret, 167, 08025 Barcelona, Spain.
Head & Neck
|November 21, 2000
Summary
Ten percent of head and neck cancer patients undergoing surgery after induction chemotherapy had a negative specimen, showing no residual tumor. These patients experienced significantly better survival rates, indicating a favorable prognosis.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Cancer Research
Background:
- Head and neck cancer patients treated with induction chemotherapy followed by surgery may present a "negative specimen" upon histologic analysis, indicating no viable tumor cells.
- This phenomenon, termed "negative specimen," requires further investigation into its frequency and clinical implications.
Purpose of the Study:
- To quantify the occurrence of negative specimens in head and neck cancer patients after neoadjuvant chemotherapy and surgical resection.
- To analyze the prognostic impact of a negative specimen on patient survival outcomes.
Main Methods:
- A retrospective analysis of prospectively collected data from 245 patients with head and neck cancer who underwent surgery post-induction chemotherapy.
- Individual patient data review for those with negative specimens, with actuarial survival calculated based on the presence or absence of residual tumor.
Main Results:
- A negative specimen was identified in 10% of the studied patient cohort (25 out of 245 patients).
- Patients with negative specimens demonstrated a significantly higher 5-year adjusted survival rate of 96% compared to 62% for those with residual tumor.
Conclusions:
- Approximately 10% of head and neck cancer patients treated with induction chemotherapy and subsequent surgery achieve a complete pathologic response.
- The absence of residual tumor in surgical specimens following neoadjuvant therapy is associated with a highly favorable prognosis and improved survival.